UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
DELISTED
Crinetics Pharmaceuticals
CRNX
| $7.57M | ﹤0.01% |
202,395
-27,733
| -12% | -$1.03M |
2020 Q2
24 quarters
|
|
1377
Silgan Holdings
SLGN
$4.21B
| $7.57M | ﹤0.01% |
163,212
-26,960
| -14% | -$1.08M |
2013 Q2
52 quarters
|
|
1378
Vanguard Extended Market ETF
VXF
$30.1B
| $7.54M | ﹤0.01% |
30,605
-368
| -1% | -$84.3K |
2025 Q4
2 quarters
|
|
1379
First Financial Bancorp
FFBC
$3.42B
| $7.52M | ﹤0.01% |
222,412
-4,035
| -2% | -$123K |
2013 Q2
52 quarters
|
|
1380
United Community Banks
UCB
$4.43B
| $7.52M | ﹤0.01% |
214,390
-26,195
| -11% | -$875K |
2015 Q1
45 quarters
|
|
1381
International Bancshares
IBOC
$4.16B
| $7.51M | ﹤0.01% |
98,945
-8,734
| -8% | -$634K |
2013 Q2
52 quarters
|
|
1382
Newell Brands
NWL
$2.15B
| $7.51M | ﹤0.01% |
1,223,869
-181,947
| -13% | -$769K |
2013 Q2
52 quarters
|
|
1383
10x Genomics
TXG
$9.22B
| $7.49M | ﹤0.01% |
195,465
-10,072
| -5% | -$264K |
2019 Q3
27 quarters
|
|
1384
Warrior Met Coal
HCC
$4.51B
| $7.48M | ﹤0.01% |
92,189
+8,207
| +10% | +$742K |
2018 Q3
31 quarters
|
|
1385
Flagstar Bank National Association
FLG
$4.35B
| $7.47M | ﹤0.01% |
500,326
-3,716
| -0.7% | -$52.7K |
2013 Q2
52 quarters
|
|
1386
CSW Industrials
CSW
$4.75B
| $7.47M | ﹤0.01% |
26,842
-281
| -1% | -$77.9K |
2019 Q2
28 quarters
|
|
1387
Napco Security Technologies
NSSC
$1.41B
| $7.45M | ﹤0.01% |
196,242
-75,785
| -28% | -$3.01M |
2023 Q1
13 quarters
|
|
1388
Freshpet
FRPT
$3.23B
| $7.44M | ﹤0.01% |
125,901
-3,720
| -3% | -$213K |
2018 Q2
32 quarters
|
|
1389
iShares 20+ Year Treasury Bond ETF
TLT
$48.1B
| $7.43M | ﹤0.01% |
85,961
-1,760
| -2% | -$151K |
2025 Q4
2 quarters
|
|
1390
DELISTED
Nuvalent
NUVL
| $7.42M | ﹤0.01% |
60,102
-62,085
| -51% | -$6.68M |
2022 Q4
14 quarters
|
|
1391
Bank of Hawaii
BOH
$2.74B
| $7.41M | ﹤0.01% |
90,911
-2,299
| -2% | -$180K |
2013 Q2
52 quarters
|
|
1392
Acadian Asset Management
AAMI
$3.19B
| $7.4M | ﹤0.01% |
103,504
+36,083
| +54% | +$2.51M |
2018 Q1
33 quarters
|
|
1393
Chefs' Warehouse
CHEF
$4.51B
| $7.38M | ﹤0.01% |
76,846
-3,162
| -4% | -$245K |
2020 Q2
24 quarters
|
|
1394
Bel Fuse Inc Class B
BELFB
$3.35B
| $7.38M | ﹤0.01% |
22,167
+2,897
| +15% | +$783K |
2023 Q3
11 quarters
|
|
1395
Whirlpool
WHR
$1.99B
| $7.37M | ﹤0.01% |
186,836
+3,448
| +2% | +$162K |
2013 Q2
52 quarters
|
|
1396
Dianthus Therapeutics
DNTH
$4.64B
| $7.35M | ﹤0.01% |
75,396
+14,961
| +25% | +$1.31M |
2025 Q4
2 quarters
|
|
1397
iShares Russell Mid-Cap Growth ETF
IWP
$18.6B
| $7.34M | ﹤0.01% |
50,156
-3,275
| -6% | -$451K |
2025 Q4
2 quarters
|
|
1398
Pegasystems
PEGA
$5.55B
| $7.34M | ﹤0.01% |
244,905
-30,274
| -11% | -$1.08M |
2013 Q2
52 quarters
|
|
1399
JBG SMITH
JBGS
$701M
| $7.33M | ﹤0.01% |
499,722
+496,696
| +16,414% | +$7.35M |
2017 Q3
35 quarters
|
|
1400
Banc of California
BANC
$2.9B
| $7.33M | ﹤0.01% |
358,830
+21,084
| +6% | +$402K |
2015 Q2
44 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.